Page last updated: 2024-10-21

3-aminobenzamide and Colorectal Neoplasms

3-aminobenzamide has been researched along with Colorectal Neoplasms in 2 studies

Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.

Research Excerpts

ExcerptRelevanceReference
" Two compounds in this series were found to potentiate the cytotoxicity of the DNA-methylating agent temozolomide by 4-5-fold in a human colorectal cancer cell line."3.72Potentiation of cytotoxic drug activity in human tumour cell lines, by amine-substituted 2-arylbenzimidazole-4-carboxamide PARP-1 inhibitors. ( Curtin, NJ; Eastman, BW; Golding, BT; Griffin, RJ; Hostomsky, Z; Kyle, S; Li, J; Maegley, KA; Skalitzky, DJ; Webber, SE; White, AW; Yu, XH, 2004)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
White, AW1
Curtin, NJ1
Eastman, BW1
Golding, BT1
Hostomsky, Z1
Kyle, S1
Li, J1
Maegley, KA1
Skalitzky, DJ1
Webber, SE1
Yu, XH1
Griffin, RJ1
Ronen, SM1
DiStefano, F1
McCoy, CL1
Robertson, D1
Smith, TA1
Al-Saffar, NM1
Titley, J1
Cunningham, DC1
Griffiths, JR1
Leach, MO1
Clarke, PA1

Other Studies

2 other studies available for 3-aminobenzamide and Colorectal Neoplasms

ArticleYear
Potentiation of cytotoxic drug activity in human tumour cell lines, by amine-substituted 2-arylbenzimidazole-4-carboxamide PARP-1 inhibitors.
    Bioorganic & medicinal chemistry letters, 2004, May-17, Volume: 14, Issue:10

    Topics: Amides; Animals; Antineoplastic Agents; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Colore

2004
Magnetic resonance detects metabolic changes associated with chemotherapy-induced apoptosis.
    British journal of cancer, 1999, Volume: 80, Issue:7

    Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Caspases; Cell Survival; Colorectal Neoplasms

1999